We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Charles River Laboratories Enters Strategic Partnership with AstraZeneca

News   Oct 19, 2012

 
Charles River Laboratories Enters Strategic Partnership with AstraZeneca
 
 
 

RELATED ARTICLES

Drug Candidate Against a Forgotten Tropical Disease

News

Researchers from the Swiss Tropical and Public Health Institute together with colleagues from Singapore have discovered a highly effective compound against Buruli ulcer which has the potential to become a powerful alternative to the existing treatment options.

READ MORE

Duchenne Muscular Dystrophy: At-home Monitoring of Lung Function Made Easier

News

Home-based monitoring shows promise as an effective way to boost patient compliance while obtaining reliable clinical information without a hospital visit.

READ MORE

How Anti-psychotic Medications Drive Weight Gain

News

About three million Americans take antipsychotic medications for conditions such as bipolar disorder, PTSD and schizophrenia. These medications are vital for mental health, yet many people stop taking them because of the side effects of weight gain and associated metabolic diseases.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE